We Want Bigger 401(k) Matches - Even When We Shouldn't
Sprint Takes On T-Mobile With $60 Unlimited Data Plan
Hoarding: What's Going on With All That Stuff?
Market Wrap: Investors Take Cover as Ukraine Tensions Flare
Is Celgene the Perfect Stock?
Biotechnology company Celgene (CELG) announced it is buying Abraxis BioScience (ABII) for $2.9 billion in cash and stock. With this acquisition, Ceglene is expanding its portfolio of cancer treatments.